In clinical trials, logistics are the invisible backbone. From investigational medicinal products (IMPs) and ancillary supplies to temperature-controlled storage and timely distribution, each element must function with precision. But what happens when a link in the chain breaks? Supply chain disruptions—caused by global events, vendor failures, regulatory hurdles, or logistical delays—can jeopardize timelines, budgets, and, […]
What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]
Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]